Page de couverture de 77 | Roy Lipski, CEO, Creo

77 | Roy Lipski, CEO, Creo

77 | Roy Lipski, CEO, Creo

Écouter gratuitement

Voir les détails du balado

À propos de cet audio

 Biosynthetic compounds — including cannabinoids — present the 'last great domestication' says Roy Lipski, CEO of Creo. His company is at the forefront of bringing lab-produced cannabinoids to market, at scale. Cosmetics and creams will be among the first products to take advantage of this technology and we can look for these products on store shelves in the not-too-distant future. Tune in to hear how:
  • Microorganisms can produce bio-identical compounds, without the waste that comes with plant-produced cannabinoids.
  • A lab can produce a year's crop worth of cannabinoids in 48 hours.
  • We can now produce 'rare' cannabinoids, at scale.
  • Creo is working with consumer packaged goods providers to integrate cannabinoids into products we use every day — like skincare products — and we can expect to see them on store shelves starting in 2022.

Hosted on Acast. See acast.com/privacy for more information.

Ce que les auditeurs disent de 77 | Roy Lipski, CEO, Creo

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.

Évaluations sur Audible.ca

Évaluations sur Amazon.ca
Il n'y a pas encore de critiques pour ce titre.